Investment Q&A

• Intrexon Corporation (XON)
  • View XON Profile
  • View Questions on XON

Q: Any thoughts on XON?
Has management delivered on their promises, is the debt high and what is the level of insider ownership?
Have they been able to sell there products at a profit?
The long term share price chart is less than stellar and the short interest appears to be high.
Thanks as always,
Jim

Upvote 0

Read Answer Asked by James on January 29, 2018

• Knight Therapeutics Inc. (GUD $5.77)
  • $5.77 Cap: $574M
  • View GUD Profile
  • View Questions on GUD
  • View Reports on GUD

Q: Why is GUD such a great investment when it holds 68% cash presently.Yet when i am holding app. 34% cash in my portfolio" many people say " that i am timing the market.Seems like both of us are waiting on an opportunity! What is your impressions of etf MOTI.

Upvote 0

Read Answer Asked by Randy on January 29, 2018

• Medicure Inc. (MPH $1.01)
  • $1.01 Cap: $10M
  • View MPH Profile
  • View Questions on MPH
• Knight Therapeutics Inc. (GUD $5.77)
  • $5.77 Cap: $574M
  • View GUD Profile
  • View Questions on GUD
  • View Reports on GUD

Q: I own MPH and think of selling and buying GUD. Your opinion please?

Upvote 0

Read Answer Asked by George on January 26, 2018

• iShares Global Healthcare Index ETF (CAD-Hedged) (XHC $66.36)
  • $66.36 P/E (TTM): 25.66X Cap: $496M
  • View XHC Profile
  • View Questions on XHC

Q: I have a question about 1536 how does Xhc look to invest in today

Upvote 0

Read Answer Asked by Gill on January 26, 2018

• Savaria Corporation (SIS $21.34)
  • $21.34 P/E (TTM): 28.12X Cap: $1.52B
  • View SIS Profile
  • View Questions on SIS
  • View Reports on SIS

Q: Having followed this company for some time a 5% drop in a day is absolutely not the norm even on a bad day, which this is not. It follows a 2.5% drop yesterday. Something is going on here other than normal trading. Are sell volumes very high and in high blocks indicating some major holder is dumping shares?

Upvote 0

Read Answer Asked by John on January 25, 2018

• Covalon Technologies Ltd. (COV $2.01)
  • $2.01 P/E (TTM): 26.12X Cap: $55M
  • View COV Profile
  • View Questions on COV
  • View Reports on COV

Q: Looking at adding a position in COV but it has really run up since your initial recommendation. Do you place price targets on your positions? If not, does this stock have a lot of room to run if added at current levels?

Thanks.

Upvote 0

Read Answer Asked by Chris on January 24, 2018

• Knight Therapeutics Inc. (GUD $5.77)
  • $5.77 Cap: $574M
  • View GUD Profile
  • View Questions on GUD
  • View Reports on GUD

Q: Good Day, I have held GUD patiently since inception, awaiting performance similair to it's predecessor. I am getting impatient, still above water but wondering how long to sit on what seems like dead money. It is now just a 3% holding. Is patience still justified???
Thanks, Lavern

Upvote 0

Read Answer Asked by Lavern on January 24, 2018

• Stericycle Inc. (SRCL)
  • P/E (TTM): 159.83X Cap: $5.75B
  • View SRCL Profile
  • View Questions on SRCL

Q: Hello everyone
Your thoughts on Stericycle

Upvote 0

Read Answer Asked by George on January 24, 2018

• Novoheart Holdings Inc. (NVH $0.53)
  • $0.53 Cap: $99M
  • View NVH Profile
  • View Questions on NVH

Q: Do you have any information and opinion on a company called Novo Heart.

Upvote 0

Read Answer Asked by Tim on January 23, 2018

• Reliq Health Technologies Inc. (RHT)
  • Cap: $47M
  • View RHT Profile
  • View Questions on RHT

Q: On Jan 19, you gave an answer to Doris of your Crystal ball not working, but GUD, RHT, and PTE provided good potential. RHT is the same symbol for Relic and Red Hat. Both sound positive, but which is being referred to in this answer. Please clarify.
Thanks

Upvote 0

Read Answer Asked by Matthew on January 22, 2018

• iShares Biotechnology ETF (IBB $149.95)
  • $149.95 P/E (TTM): 18.7X Cap: $6.16B
  • View IBB Profile
  • View Questions on IBB
• SPDR Biotech ETF (XBI $104.99)
  • $104.99 P/E (TTM): 15.46X Cap: $6.23B
  • View XBI Profile
  • View Questions on XBI
• Vanguard Health Care ETF (VHT $264.73)
  • $264.73 P/E (TTM): 23.36X Cap: $15.07B
  • View VHT Profile
  • View Questions on VHT

Q: Could you please recommend an ETF relating to the healthcare sector please (possibly 3)? Should it be North American focused or more Global?
Thanks!

Upvote 0

Read Answer Asked by Brian on January 22, 2018

• Knight Therapeutics Inc. (GUD $5.77)
  • $5.77 Cap: $574M
  • View GUD Profile
  • View Questions on GUD
  • View Reports on GUD

Q: Mr. Hodson, what is GUD likely to do with its hoard of cash ? No use to keep all that money if it is not put to some use !

Upvote 0

Read Answer Asked by Serge on January 21, 2018

• ProMIS Neurosciences Inc. (PMN $6.00)
  • $6.00 Cap: $322M
  • View PMN Profile
  • View Questions on PMN

Q: Could you please comment on PMN, Promis Neurosciences Inc., and if you would consider this a buy based on fundamentals, news, or any other information you may have on this biotech company.
Thanks
George

Upvote 0

Read Answer Asked by George on January 21, 2018

• CRH Medical Corporation (CRH $4.99)
  • $4.99 Cap: $357M
  • View CRH Profile
  • View Questions on CRH

Q: Hello,crh seems to be making a good recovery,would you be ok adding to a half position?
Or do you think I should sell and move on.
Thanks

Upvote 0

Read Answer Asked by Brad on January 20, 2018

• Knight Therapeutics Inc. (GUD $5.77)
  • $5.77 Cap: $574M
  • View GUD Profile
  • View Questions on GUD
  • View Reports on GUD

Q: Thank you for all your solid advice - you really provide a great service. I am concerned about the lack of activity/inaction with GUD. Is there a timeframe you deem appropriate before you downgrade this company due to inactivity?

Upvote 0

Read Answer Asked by George on January 19, 2018

• Savaria Corporation (SIS $21.34)
  • $21.34 P/E (TTM): 28.12X Cap: $1.52B
  • View SIS Profile
  • View Questions on SIS
  • View Reports on SIS

Q: With Savaria being in an industry with tailwinds might a larger medical services try and asquire them?? Thx

Upvote 0

Read Answer Asked by blake on January 19, 2018

• Bristol-Myers Squibb Company (BMY $43.96)
  • $43.96 P/E (TTM): 17.94X Cap: $89.47B
  • View BMY Profile
  • View Questions on BMY

Q: Any reason for the 3% drop today? Is this related to the Keytruda results from a competitor.

Upvote 0

Read Answer Asked by kelly on January 17, 2018

• Knight Therapeutics Inc. (GUD $5.77)
  • $5.77 Cap: $574M
  • View GUD Profile
  • View Questions on GUD
  • View Reports on GUD
• Acasti Pharma Inc. (ACST $0.58)
  • $0.58 Cap: $8M
  • View ACST Profile
  • View Questions on ACST

Q: Moving to stage 3 on their collestoral drug that is supposed to be better than anything on the market. Small market cap, but success could be around the corner. Please give your opinion of the company and your thoughts on a trade from sleepy GUD. Thank you 5i.

Upvote 0

Read Answer Asked by Richard on January 17, 2018

• Savaria Corporation (SIS $21.34)
  • $21.34 P/E (TTM): 28.12X Cap: $1.52B
  • View SIS Profile
  • View Questions on SIS
  • View Reports on SIS

Q: Savaria is a small company in what seems to be a fairly fragmented market. What are their competitive advantages? Do they benefit from patents? Who are there primary competitors?

Bought a full position on your recommendation and it has run up nicely from the ~$14 range. Would you continue to hold? Also, what is the forward PE multiple?

Thanks very much!

Upvote 0

Read Answer Asked by Jeffrey on January 16, 2018

• IMV Inc. (IMV $1.12)
  • $1.12 Cap: $13M
  • View IMV Profile
  • View Questions on IMV

Q: Can you update your opinion of this company.It seems to be acting very well recently, at least from a technical perspective. Apparently there has been some insider buying recently.
Thinking of take a small position at this time.Would like your opinion on doing so.

Upvote 0

Read Answer Asked by Thomas on January 16, 2018